Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2008
NCT00893711
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna | Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology | Prof. Franca Fagioli

Active Ingredients

Drugs in Phase 4 Trials (1)

polyethylene glycol (1 trial)

Drugs in Phase 3 Trials (1)

clonidine (catapres) (1 trial)

Drugs in Phase 2 Trials (2)

chloroprocaine (nesacaine) (1 trial)

dinutuximab (unituxin) (1 trial)

Drugs in Phase 1 Trials (1)

autologous cytokine induced killer cells (2 trials)

Drugs in Other Trials (2)

lactobacillus reuteri (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Constipation (Phase 4)

Fecal Impaction (Phase 4)

Flatfoot (Phase 2)

Hernia (Phase 2)

Hernia, Inguinal (Phase 2)

Hyperemesis Gravidarum (Phase 3)

Sarcoma (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 7